SOM Biotech Overview

  • Founded
  • 2009
  • Status
  • Private
  • Employees
  • 15
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $8.27M
Latest Deal Amount
  • Investors
  • 6

SOM Biotech General Information


Developer of drugs designed for the treatment of rare and critical diseases. The company's AI-based drug discovery technology allows reducing costs and time for drug development, providing a high level of success and reliable patent protection and engages in the development of candidates, drug pipeline and compounds to treat diseases, enabling the medical community to optimally combat acute and life-threatening diseases while maintaining safety and tolerance standards.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Baldiri Reixac, 4
  • 08028 Barcelona
  • Spain
+34 934 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SOM Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 08-Mar-2019 $8.27M 000.00 0000 Completed Generating Revenue
6. Later Stage VC 17-Jan-2017 00.00 00.00 Completed Generating Revenue
5. Product Crowdfunding 02-Feb-2016 00.000 00000 Completed Startup
4. Grant 10-Oct-2013 000.00 00000 Completed Startup
3. Grant 30-Oct-2012 00000 00000 Completed Startup
2. Grant 13-Sep-2012 $528K $992K Completed Startup
1. Early Stage VC 01-Jan-2011 $992K $992K Completed Startup
To view SOM Biotech’s complete valuation and funding history, request access »

SOM Biotech Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
preference 00,000,000 00.00 00.00 00 00.00 00.000
To view SOM Biotech’s complete cap table history, request access »

SOM Biotech Executive Team (14)

Name Title Board Seat Contact Info
Raúl Insa Founder, Chief Executive Officer & President
Marc Casellas Chief Financial Officer
Kevin McAllister Ph.D Chief Scientific Officer
Saurabh Mishra Chief Analytics Officer
Oscar Huertas Ph.D Head of Drug Discovery
You’re viewing 5 of 14 executive team members. Get the full list »

SOM Biotech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SOM Biotech Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Additio Investment Group Venture Capital Minority 000 0000 000000 0
Convergence Partners (Switzerland) Venture Capital Minority 000 0000 000000 0
Health Technology Holding Venture Capital Minority 000 0000 000000 0
Empresa Nacional de Innovación Venture Capital Minority 000 0000 000000 0
Spanish Ministry of Energy, Industry and Tourism Government 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »